University Hospital of Wales, also known as the Heath Hospital, is a major 1,000-bed hospital in the Heath district of Cardiff, Wales. UHW is a teaching hospital of Cardiff University School of Medicine. Construction started in 1963, with the official opening in 1971.

There are 1,080 beds in University Hospital of Wales.

During the past decade, University Hospital of Wales conducted 139 clinical trials. In the 10-year time frame, 139 clinical trials started and 55 clinical trials were completed, i.e. on average, 39.6% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 37 clinical trials were completed. i.e. 61.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospital of Wales" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Cardiff University" with 8 trials sponsored, "Cardiff and Vale University Health Board" with 8 trials sponsored, "Gilead Sciences" with 8 trials sponsored and "Ipsen" with 8 trials sponsored. Other sponsors include 177 different institutions and companies that sponsored additional 129 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospital of Wales" #1 collaborator was "Cancer Research UK" with 5 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Cardiff University" with 3 trials as a collaborator, "Copenhagen Trial Unit, Center for Clinical Intervention Research" with 3 trials as a collaborator and "Lund University" with 3 trials as a collaborator. Other collaborators include 165 different institutions and companies that were collaborators in the rest 159 trials.

According to Clinical.Site data, the most researched conditions in "University Hospital of Wales" are "Leukemia" (7 trials), "Multiple Myeloma" (7 trials), "Prostate Cancer" (7 trials), "Anemia" (6 trials) and "Breast Cancer" (6 trials). Many other conditions were trialed in "University Hospital of Wales" in a lesser frequency.

Most popular intervention types in "University Hospital of Wales" are "Drug" (144 trials), "Other" (38 trials), "Device" (26 trials), "Procedure" (26 trials) and "Biological" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Dexamethasone" (6 trials), "Rituximab" (6 trials), "Lenalidomide" (5 trials) and "Sham Procedure" (5 trials). Other intervention names were less common.

The vast majority of trials in "University Hospital of Wales" are 197 trials for "All" genders, 17 trials for "Male" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "University Hospital of Wales". undefined are not yet recruiting, 37 are recruiting, 28 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 116 completed trials in University Hospital of Wales, undefined suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospital of Wales, 21 "Phase 1" clinical trials were conducted, 47 "Phase 2" clinical trials and 98 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 29 trials that are defined as “Not Applicable".

University Hospital of Wales has several departments that took part in Clinical trials: "South West Wales Cancer Institute" - 18 trials, "Singleton Hospital; Pharmacy Department" - 6 trials, "Childrens Hospital for Wales" - 40 trials, "Dept. of Nephrology, Morriston Hospital" - 2 trials, "University Hospital of Wales, Dept of Neurology" - 2 trials, "Wound Healing Research Unit" - 2 trials, "Velindre Cancer Centre; Clinical Trials Unit" - 2 trials